Tackling the emerging threat of antifungal resistance to human health

MC Fisher, A Alastruey-Izquierdo, J Berman… - Nature reviews …, 2022 - nature.com
Invasive fungal infections pose an important threat to public health and are an under-
recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …

[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions

AI Abulsoud, HM El-Husseiny, AA El-Husseiny… - Biomedicine & …, 2023 - Elsevier
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …

Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India–Collaborative OPAI …

M Sen, SG Honavar, R Bansal… - Indian journal of …, 2021 - journals.lww.com
Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …

Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 …

L Russell, KR Uhre, ALS Lindgaard, JF Degn… - Jama, 2021 - jamanetwork.com
Importance A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in
patients with severe and critical COVID-19, but a higher dose may benefit those with more …

COVID-19 and mucormycosis superinfection: the perfect storm

JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah… - Infection, 2021 - Springer
Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …

Diagnosis of invasive fungal infections: challenges and recent developments

W Fang, J Wu, M Cheng, X Zhu, M Du, C Chen… - Journal of biomedical …, 2023 - Springer
Background The global burden of invasive fungal infections (IFIs) has shown an upsurge in
recent years due to the higher load of immunocompromised patients suffering from various …

ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries

SM Rudramurthy, M Hoenigl, JF Meis, OA Cornely… - Mycoses, 2021 - Wiley Online Library
Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

Mucormycosis and COVID‐19: an epidemic within a pandemic in India

L Selarka, S Sharma, D Saini, S Sharma, A Batra… - Mycoses, 2021 - Wiley Online Library
Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …

COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India

JM Aranjani, A Manuel, HI Abdul Razack… - PLoS neglected …, 2021 - journals.plos.org
Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021, has caused
devastating chaos in India. As daily infection rates rise alarmingly, the number of severe …

[PDF][PDF] Сахарный диабет и COVID-19

МН Хамидова, ИФ Исматова… - … и естественных наук, 2022 - in-academy.uz
EURASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES Page 1 EURASIAN
JOURNAL OF MEDICAL AND NATURAL SCIENCES Innovative Academy Research Support …